{"schema_version":"secwatch.filing_event.v1","accession":"0001808805-25-000054","form_type":"8-K","ticker":"NAUT","cik":"0001808805","company_name":"Nautilus Biotechnology, Inc.","filed_at":"2025-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.812166+00:00","generated_at":"2026-05-18T23:59:56.075751+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Nautilus Biotechnology elects Class I directors, ratifies PwC, reduces board size to 7","bullets":["Sujal Patel re-elected with 84.3M votes for; Matthew McIlwain elected with 82.2M votes for.","PricewaterhouseCoopers LLP ratified as auditor for 2025 with 99.5M votes for.","Board reduced from 9 to 7 directors effective after annual meeting.","Directors Vijay Pande and Michael Altman did not stand for re-election; McIlwain resigned as Class II to stand for Class I."],"urls":{"canonical":"https://secwatch.observer/filing/0001808805-25-000054","json":"https://secwatch.observer/filing/0001808805-25-000054.json","markdown":"https://secwatch.observer/filing/0001808805-25-000054.md","text":"https://secwatch.observer/filing/0001808805-25-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000054/0001808805-25-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000054/naut-20250620.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T23:59:56.075751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}